These strategies aim to address different aspects of metabolic dysfunction while building on the proven benefits of incretin-based therapy
Medical circumstances vary between individuals always seek advice from a qualified healthcare professional before making decisions about health, treatment, or participation in clinical research
Patient monitoring should include: Baseline lipid panel, hemoglobin A1c, and liver function tests Blood pressure monitoring (GLP-1 agents typically reduce systolic BP by 3-5 mmHg) [10] Assessment for gastrointestinal adverse effects during dose titration Evaluation for contraindications (personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2) [1] [3] Monitoring for gallbladder disease (increased risk with rapid weight loss) In patients with diabetes and retinopathy, monitoring for worsening eye symptoms, particularly with rapid glycemic improvement Renal function assessment, especially if severe gastrointestinal symptoms cause dehydration Patients should seek immediate medical attention for severe abdominal pain, which may indicate pancreatitisa rare but serious adverse effect
INRA Prod Anim
they multiply rapidly during pregnancy
Special nutrition intervention is required for muscle protective efficacy of physical exercise in elderly people at highest risk of sarcopenia
